The demyelination process is an important factor contributing to long term sensory and motor impairments after spinal cord injury (SCI). Exposure of axonal K + channels after demyelination may contribute to blockage of action potentials across the injury site. A K + channel blocker, 4-aminopyridine (4-AP), has been eective in restoring some sensory and motor impairment in incomplete SCI patients. The long-term eect of this compound in chronic model of SCI is not known. In this study, after a compression injury of 50 grams in rats, a randomized treatment was initiated 3 weeks after the initial injury which was followed by daily administration of 4-AP at 2 mg/kg (n=8), 4 mg/kg (n=8), and 6 mg/kg (n=8) for 4 weeks. A group of methylprednisolone (MP)-treated (30 mg/kg, n=8) and non-treated animals (n=8) were included for comparison. The functional motor outcome was measured in each animal at regular time points up to 4 weeks post-treatment. All animals receiving 6 mg/ kg developed generalized seizure and were excluded from the study. In the other animal groups, analysis of the behavioral outcome and neuro-pathological changes were essentially similar and did not show any signi®cant eect of treatment. Our data indicate that daily administration of 4-AP, over 4 weeks of treatment period, lacks any signi®cant eect on axonal function in chronically injured rats. This could be due to (a) lack of signi®cant numbers of demyelinated axons which could improve the functional outcome and (b) a treatment regimen that was not adequate to contribute to a better functional outcome. One time bolus-administration of MP at 30 mg/kg also did not ensure a better functional outcome.
Introduction
In chronic spinal cord injury (SCI), demyelination has been shown to be an important factor contributing to long term sensory and motor impairments. 1 ± 4 The loss of myelin sheath around myelinated axons promotes the exposure of K + channels in the internodal region, which leads to an excessive K + eux into the extracellular space and subsequent blockage of nerve action potentials. 5, 6 This event is similar to voltage clamping of the cell membrane close to the K + equilibrium potential (E k ), thus opposing depolarization and interfering with nerve conduction in demyelinating axons. 7 Therefore, voltage-sensitive K + channel blockers should, at least in theory, facilitate propagation of impulses through demyelinated segments of axons. Dierent K + channel blockers have been used in demyelinating diseases such as multiple sclerosis 8 ± 11 with some clinical improvement. Among these compounds, 4-Aminopyridine (4-AP) has been also eective in restoring some sensory and motor impairment in chronic, but incomplete, spinal cord injuries in clinical trials or experimental animals. 1,12 ± 15 Administration of 4-AP at 0.5 ± 1 mg/kg has produced immediate amelioration of de®cits in canine paraplegia. This functional recovery occurred within 15 ± 45 min of the drug administration but it fully reversed within a few hours. 15 The initial clinical trial for application of 4-AP in patients with SCI was an open, unblinded study using 2 mg every 20 min up to 24 mg of the compound. 1 This treatment did not bene®t patients with complete SCI. In complete injuries, there was evidence of enhanced neurologic function, however, this improvement was not functionally important. In a more recent clinical trial, 4-AP was given to eight patients in a randomized, double-blind, crossover fashion. 12 4-AP was associated with signi®cant but transient neurological improvement in ®ve of six patients. In this study, because the eect of 4-AP persisted over 48 h after termination of the drug infusion, authors speculated that there were other therapeutic mechanisms than the primary eect of 4-AP on K + channels. In experimental trials, the levels of neurological recovery was limited by 4-AP dosage. 16 In dogs, 4-AP administration has produced adverse reactions such as anxiety, nervousness and seizures.
The objective of the present study was to determine if a long term (4 weeks) administration of the 4-AP would improve functional recovery in chronic model of SCI in rats. An additional group of animals treated with single dose of methylprednisolone was included in the study for comparison with a more traditional therapy.
Materials and methods

Surgical procedures and post operative care
Forty male rats (Harlan Sprague-Dawley Inc., Indianapolis, IN) weighing 473+51 gm were used. Animals were housed individually and maintained in a 12 h light/dark cycle. Halothane anesthesia was induced at 4% after placing the animals in a plastic chamber. The anesthetized animals were transferred and ®xed to a steriotactic frame (Model 1404, David Kopf Instruments, Tujunga, California) and were placed in a prone position on a heating blanket (Aquamatic K-model and K-pad, Gorman Rupp Industries, Belleville, Ohio). Body temperature was maintained between 36.58C and 37.58C (Model 401, rectal thermomenter, Yellow Springs Instruments Co, Yellow Springs, Ohio). Halothane anesthesia was continued by mask. The EKG was continuously monitored using a physiograph.
Under sterile conditions, a midline incision at the lower thoracic level was performed. Under microscope, a T10-T11 dorsal laminectomy was performed. An aluminum compression device (weighing 5 g) with a rectangular concave contact surface (464 mm) and a round platform was positioned on the dorsal midline of the spinal cord using a micropositioner. 17 The compressive injury was produced by placing a 45 g weight on the platform (total compression weight=50 g) for 90 s.
After the injury, the wounds were closed in layers and the animals were placed into cages. Animals received ampicillin 50 mg/kg IM before and every 6 h after the surgery up to 24 h. Buprenorphine 0.01 mg/ kg SQ was also administered to relieve postoperative pain. The urinary bladder was expressed in each animal four times a day until full recovery of spontaneous micturition occurred.
Drug administration
Rats were randomly placed into ®ve groups. Group#1 (n=8) received an intraperitoneal bolus dose of methylprednisolone (30 mg/kg) immediately after the injury. Groups # 2, 3, 4 received daily I.P. injections of 4-AP at 2 mg/kg (n=8), 4 mg/kg (n=8), and 6 mg/kg (n=8) starting at the 3rd weeks post-injury through the 7th weeks. Animals receiving 6 mg/kg 4-AP developed generalized seizure immediately after the ®rst dosage administration. Treatment was terminated, and this group was excluded from the study. Control group (n=8) received an equal volume of bacteriostatic saline post-injury.
Behavioral assessment
All animals were closely monitored for 7 weeks after the initial injury. During this period, each animal was subjected to a behavior examination using the included plane (IP), toe spreading re¯ex (TSR) and a modi®ed Tarlov's scale (TS). The IP task measures the animal's ability to maintain its body position when placed on an inclined board. 18 The TSR is elicited after picking the animal and allowing the hindlimbs to hang free. 19 The TS indicates the animal's hindlimb locomotor ability. 20 Each animal was tested prior to the injury (Day 0) and at days 1, 3, 5, 7, 14, 21, 28, 35, 42, 49 post-injury. These tests were performed, in a blinded fashion, by a second investigator unaware of the treatment schedule.
Histological preparation of spinal cord
After termination of the treatment period (49th day postinjury), three animals in each group were selected for histology. These animals were sacri®ced by intracardiac perfusion with 10% buered formalin under deep level of pentobarbital anesthesia. Ten mm of spinal cord inclusive of the injured segment was removed and immersed in zinc buered formaldehyde or phosphate buered glutaraldehyde. Specimens were incised from side to side longitudinally, slightly above the level of the spinal roots. The dorsal half of the cord was embedded in paran, and four series of 5 mm-thick sections were made at 100 mm intervals, beginning 100 mm into the tissue. One section in each series was stained with HE, one with Luxol Fast Blue (LFB)-PAS stain for myelin and one with Sevier-Munger stain for axons, using standard histologic methods.
Sections were evaluated using four criteria on light microscopic examination. Three of the criteria were designed to assess the amount of tissue destruction. Malacia, if present, was scored as being 0 ± 4 in severity, according to the estimated proportion of the specimen's width aected in the most severely aected section. The amount of Wallerian degeneration was evaluated by assessing the degree of vacuolation and axonal degeneration distal to the central area of malacia. The amount of axonal loss proximal to the central focus of malacia was evaluated by examining Sevier-Munger stained tissues. The sum to these three scores, averaged over the four step-sections examined in each animal, was used to summarize the overall degree of histological tissue damage in the spinal cord specimens. The degree of reparative response was assessed by estimating the relative increase in the number of non-macrophage glial cells in the white matter proximal to the malacic lesion.
Statistical analysis
In this study we were primarily interested in comparing the groups at the end of the treatment time. The IP data were interval-scaled data and lent itself to a dierent analysis than the data on TSR and TS, which were ordinal.
For the IP, a repeated measures analysis of variance was used. Repeated measures were being taken at the 42nd and 49th post-injury day and tested for group eects. Since there was some indication that there was more viability in the outcomes for the control group than the other groups, we also did some nonparametric comparisons for each time point. The Kruskal Wallis and Median tests were used. We also tested to see if the groups were comparable at baseline (preinjury). On the chance that the initial value might be related to the ®nal inclined plane value, we used a relative measurement and de®ned RIP49=IP49/IPO. This value is essentially a percentage of the baseline value.
Since the TS were observed to range from two to ®ve and since they were on an ordinal scale, a Kruskal Wallis test was used. For the TSR the Fisher's Exact test was used to compare the groups. Table 1 depicts the summary of the behavioral scores given to the control and the -treated animals before and after the compressive injury. The recovery curves for the IP and TS assigned to the groups are shown in Figures 1 and 2 . Since 4-AP treatment was started at 21 days post-injury, the 2 mg/kg and the 4 mg/kg 4-AP groups were actually given identical care up to 21 days. One would expect no dierence in the groups up to 21 days. For the IP (Figure 1) , the repeated measure analysis of variance taken at the 42nd and 49th day post-injury showed no signi®cant dierence across groups (P=0.21). Since more variability in the outcome was seen for the control group, we performed nonparametric comparisons for each day using a Kruskal Wallis test. The results were consistent with the parametric analysis showing no signi®cant group eect. Analysis of the TS (Figure 2) showed no signi®cant treatment eect at 49th day post-injury (P=0.26). The Fisher's Exact test on the TSR also showed no signi®cant dierence between groups (P=1.0).
Results
The microscopic appearance of the cord was similar between the control and the 4-AP-treated groups with considerable variation between individual animals. A majority of the rats had areas of malacia in the center of the spinal cord sampled that aected both the dorsal gray and white matter. The malacic cavities were irregular in shape, and diered in extent between the dierent step sections of a given specimen; in several cases there was rupture of the cavitation into the central canal of the cord. Malacic areas were characterized by irregular cavities (Figure 3 ), which were traversed by strands of connective tissue and small blood vessels. Foamy to granular macrophages, stained strongly with PAS, crowded the cavity lumens.
Distal to malacic foci, vacuolar change was usually the most widespread and swollen or fragmented axons occurred together with loss of myelin-staining and vacuolar change, suggesting they were areas of Wallerian degeneration. Sevier-Munger stains indicated almost no axonal preservation distal to the central part of the specimen in any of the spinal cords.
At proximal end of the specimen, there was variable preservation of axons, and additional vacuolar change was present (Figures 4 and 5) . Numerous digestion vacuoles were present along swollen axon sheaths, and many of these LFB-positive macrophages were present. However, but segments of swollen and degenerating axons were also present ( Figure 4) .
Besides macrophages, numerous non-vacuolated polygonal glial cells were noted associated in degenerating white matter, both in the presence and absence of axons (Figure 4 ). While these cells could not be identi®ed with certainty given the histochemical techniques used, their polygonal shape suggests they were probably Schwann cells, oligodendrocytes or astrocytes instead of macrophages.
Quantitative lesion scores for both degenerative changes and glial proliferation were extremely similar 
Discussion
Spinal cord injury is associated with variety of neuropathological changes which develop at an early or later stages of the injury. These events take place sequentially, with gray matter central hemorrhage as the primary ®nding. This event is followed by necrosis of the gray matter, and later in the surrounding white matter. In rats, changes aecting myelinated axons are seen approximately 4 days or later after the injury. However, distortion of myelin sheaths occurs as early as 1 to 4 h post-injury. 21 ± 22 Neural conduction is impaired by damage of the axon's myelin sheath. The injury leads to exposure of K + channels in the internodal region of the axon, 1 and the aux of K + through the membrane blocks the conduction of action potentials. 4-AP, has all the characteristics of K + channel blockers. Blockade of K + channels is excitatory which results in prolongation of excitatory states in neurons and increasing neurotransmitter release and smooth muscle contraction. 4-AP has been shown to be eective in restoring loss of some sensory and motor functions in chronic but incomplete SCI models using a 1 mg/kg IV dose, which is within the limit of safety in animals. In chronic and incomplete injuries, 18 ± 25 mg IV of 4-AP has resulted in improvement in sensory scores, chronic pain and spasticity. 12 However, only slight improvement has been observed in motor function. The initial 4-AP trial in SCI patients was through intravenous delivery of 2 mg every 20 min up to 24 mg. This trial included six patients with chronic spinal cord injury: three with complete and three with incomplete lesions. 1 The patients with complete paralysis did not bene®t from 4-AP. The patients with incomplete injuries showed some evidence of improvement in neurological function. None of these patients had any side eects due to 4-AP administration. Nevertheless, 4-AP is a compound with toxic eects such as promoting neurotransmitter release and enhancement of neuronal excitability, inducing spontaneous synchronous activity which provokes seizures. 1, 15 In fact, our experimental rats treated with 6 mg/kg of 4-AP developed generalized seizures immediately after the initial 4-AP administration.
In our study, we measured functional recovery of the chronically injured animals after daily administration of 4-AP at 2 mg/kg and 4 mg/kg for period of 4 weeks. The neurological outcome was measured in each animal within 15 min after administration of 4- Figure 1 Treated (2 mg/kg (n=8), 4 mg/kg (n=8), methylprednisolone (n=8) and non-treated inclined plane (IP) scores. Recovery curves indicate the mean scores of each group at each time point tested (pre-injury scores at day 0). No statistically signi®cant dierence was observed at any time between the groups AP to ensure capturing possible transient improvements, as reported by others. 15 The neurological scores obtained at day 49 post-injury was not signi®cantly better than the non-treated control animals. This negative ®nding could be due to (a) lack of significant number of demyelinated axons which contribute to Figure 4 Higher magni®cation of a lesion proximal to an area of malacia demonstrates partial preservation of axons, as well as areas of axonal loss, Sevier-Munger stain. Bar=200 mm Figure 3 Longitudinally sectioned spinal cord from a 4-aminopyridine treated rat, Sevier-Munger stain. Longitudinal sections of degenerating axons (black), frame a central malacic cavity, from which both axons and myelin are absent. Bar=200 mm functional outcome, (b) treatment dosage given was not adequate to provide sucient 4-AP plasma concentration to contribute to a better functional outcome. The unresolved issues would still be the timing of the 4-AP treatment initiation, duration of the treatment, and`optimum' treatment dosage. Further experimental studies are needed at higher injury levels, lower doses 4-AP doses (0.5 ± 1 mg/kg), and dierent time windows for the treatment.
Large doses of methylprednisolone (MP) given shortly after SCI, signi®cantly enhance recovery following the injury. 23, 24 This eect is probably achieved by the reduction of the lipid peroxidation, facilitation of impulse generation, or enhancement of spinal cord blood¯ow. 25 ± 27 The lipid peroxidation process plays a crucial role in the evolution of the secondary changes in the injured spinal cord. This fact has been linked to the postinjury microvascular damage and hypoperfusion, which lead to the secondary ischemic events in the tissue. 28 Therefore, the importance of prompt treatment (less than 8 h after trauma), has been recognized. 23 In regard to the eect of steroid, several negative ®ndings have been reported. 27 High-dose of MP (1000 mg bolus and daily for 10 days) failed to improve recovery of motor or sensory function at 6 weeks and 6 months. 23 However, if given within 8 h after injury, it signi®cantly improved the neurologic recovery. 23 In an experimental study to investigate the eect of MP on vascular injury associated with SCI, bolus injection of MP given at 30 mg/kg did not signi®cantly aect the vascular injury index. 29 Based on a similar model of injury, it was shown that while a single dose of MP at 30 mg/kg attenuated lactic acidosis in spinal tissue, the lactate levels rebounded to high levels soon after the elimination of the steroid. 30 Nevertheless, 30 mg/kg dosage given to contused cats, signi®cantly improved recovery of evoked responses. 31, 27 Hall and his colleagues have reported the protective eect of 30 mg/kg MP in spinal cord ischemia resulting from spinal injury. 24 In our study the single 30 mg/kg bolus injection of MP, given immediately after the injury, did not have any signi®cant long-term bene®cial eect in rats. The improvement in behavioral scores at 49 days postinjury was not any greater than those of control animals. Therefore, it appears that a single dosing is not ideal and supports a prolongation of dosing to maximize the chances of recovery.
Because of the small size of the specimens, the challenge of uniform tissue sampling, biological variations in the size and shape of the malacic cavity and in the location of the malacic segment within the spinal cord sample, it was not possible to examine exactly the same level of each lesion produced by mechanical trauma. However, portions of malacic cord were probably observed if they were present, because soft or cavitated tissue was apparent during preparation of the specimens. While the longitudinal orientation of the cord allowed ®ber tracts transversing through the malacic areas be examined, the amount of adjacent tissue captured in the specimen probably varied according to the level and extent of malacia. These physical aspects of tissue handling probably re¯ected some of the variation observed in lesion scores.
Whenever malacia was present, downstream axonal degeneration produced Wallerian degeneration towards the cephalic end of the animal, in rough proportion to the size of the central malacic focus. Thus it is not appropriate to evaluate the amount of demyelination produced at these sites, because the majority of vacuolar change would be secondary to axonal loss. Axonal survival was evaluated on the opposite (caudal) side of the lesion, and signi®cant axonal loss was still apparent in both treated and untreated animals. Such changes could re¯ect proximal dying back of axons secondary to the malacia or loss of axons after a primary demylelinating event. Whichever the cause, the lesions produced by compression in our rats appear more complex than those lesions induced by lysolecithin injection alone, 32 in that axonal preservation within areas of myelin loss was less extensive. The presence of both primary and secondary demylelination in these areas also contributed to high lesion scores. 
